News Releases
Tefina Increased Number of Orgasms for Women
Trimel Pharmaceuticals Corporation (TSX: TRL) announced today top-line results of its Phase II clinical trial evaluating the efficacy and safety of Tefina™, a “use-as-required” testosterone nasal gel for the treatment of Female Orgasmic Disorder (FOD).
Tendex Issues Voluntary Nationwide Recall of P-Boost, NatuRECT Due to Undeclared Active Ingredients
Tendex is voluntarily recalling Lot# F51Q of P-Boost and Lot # F51Q of NatuRECT to the consumer level.